Applied Dna Scns (NQ: APDN )
6.680 USD +0.090 (+1.37%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 11, 2021 Add to My Watchlist
Press releases about Applied Dna Scns
Applied DNA Sciences and A&E Introduce Anti-Counterfeiting Technology for Sustainable Sewing Threads
June 08, 2021
Applied DNA and A&E come together to bring an innovative and economical solution to brands to authenticate and validate their products.
Applied DNA Reports Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort Against B.1.1.7, P1, and B.1.526 Variants and Sets August 2021 Mink Challenge Trial La
June 07, 2021
Applied DNA veterinary COVID-19 vaccine induces NAbs against B.1.1.7, P1, and B.1.526 variants; Set launch of mink challenge trial for August.
Applied DNA Adds First Summer Camp for safeCircle Pooled COVID-19 Surveillance Testing
June 02, 2021
The acquisition of safeCircle’s newest client reflects the service’s focus on profitable niche markets and the re-opening of venues for new sales.
Thinking about buying stock in Applied DNA Sciences, Sundial Growers, New Oriental Education, BlackBerry, or Evofem Biosciences?
May 26, 2021
Applied DNA Completes Technical Validation of PCR-based SARS-CoV-2 Mutation-Detection Panel, Highlights Ability to Rapidly Identify Mutations and Probable Variants
May 26, 2021
Applied DNA Completes Technical Validation of SARS-CoV-2 Mutation Detection Panel; Developing Mutation that Characterizes Indian Variant.
Applied DNA Provides Clarification on Newly Authorized Asymptomatic Serial Screening Indication for LineaTM COVID-19 Assay Kit and Press Release Published 12 May 2021
May 13, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), today clarifies the scope of its newly authorized asymptomatic serial screening indication for its Linea COVID-19 Assay Kit...
Applied DNA Second Fiscal Quarter 2021 Financial Results Feature 384% Year-Over-Year Growth in Revenues
May 13, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced consolidated financial results for the three and six...
FDA Grants EUA to Applied DNA LineaTM COVID-19 Assay Kit for Asymptomatic Screening of Individuals with Serial Testing
May 12, 2021
Linea™ COVID-19 Assay Kit EUA expanded to include asymptomatic serial screening as an expansion of intended use.
Applied DNA Receives CLIA Certification, Enabling High Throughput Diagnostic COVID-19 Testing
May 11, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its Applied DNA Clinical Labs, LLC...
Applied DNA Schedules Fiscal 2021 Second Quarter Financial Results Conference Call and Webcast for Thursday, May 13, 2021
May 07, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that it will report fiscal 2021 second...
Applied DNA and Evvivax Announce that LinearDNA™ COVID-19 Vaccine Candidate Booster Yields 5-Fold Average Increase in Neutralizing Antibody Titers in Domestic Felines
May 06, 2021
Testing showed that neutralizing titers were detected in feline sera with a geometric mean titer for the cohort of 398.
New contract with U.S. Defense Logistics Agency continues support of counterfeit mitigation program running since 2014.
Applied DNA Secures Amendment to Master Services Agreement and Fourth Blanket Purchase Order from Linea™ COVID-19 Assay Kit Customer
April 26, 2021
Applied DNA secures amendment doubling maximal value of MSA and receives 4th purchase order from current COVID-19 Assay Kit customer.
Applied DNA Provides Preliminary Estimated Fiscal Second Quarter 2021 Revenue Range and Business Update
April 21, 2021
Applied DNA provides preliminary estimated FQ2'21 revenue range of $2.5 million to $2.7 million and business update.
Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA™ COVID-19 Vaccine Candidate in Felines
April 12, 2021
Preliminary results of phase I clinical trial yields high titers of SARS-CoV-2 neutralizing antibodies from all cohort members.
Applied DNA CEO Discusses Relevance of DNA-based Cotton Traceability as Enabler of Ethical and Responsible Textile Manufacturing on BBC Business Daily
April 08, 2021
Applied DNA CEO discusses relevance of DNA-based cotton traceability in textile manufacturing in interview with BBC.
Applied DNA and Northwell Health Establish SARS-CoV-2 Mutation and Variant Tracking Program
April 07, 2021
Applied DNA and Northwell establish a real-time surveillance program to track and identify SARS-CoV-2 mutations and variants of concern.
Applied DNA Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development
April 01, 2021
Clay Shorrock rejoins the Company effective immediately to serve on the executive leadership team as Chief Legal Officer and Exec. Dir., B. Dev.
Applied DNA Receives Blanket Purchase Order for Linea™ COVID-19 Assay Kits for 10,000 Tests
March 11, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the receipt of a purchase order for its Linea™ COVID-19...
Applied DNA Launches Linea™ COVID-19 Selective Genomic Surveillance™ Mutation Panel to Boost SARS-CoV-2 Variant Detection and Tracking Nationally
March 09, 2021
Applied DNA Launches Selective Genomic Surveillance Screening Platform for SARS-CoV-2 Variant Detection and Tracking.
Applied DNA to Participate in Upcoming Conferences
March 08, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, will be participating in the following virtual investor...
Thinking about buying stock in Greenlane Holdings, vTv Therapeutics, Evolus Inc, Applied DNA Sciences, or Mogo Inc?
March 03, 2021
Applied DNA and Evvivax Initiate Phase I of Clinical Trial to Evaluate LinearDNA™ COVID-19 Vaccine Candidate for Feline Veterinary Market
March 02, 2021
If the veterinary vaccine candidate demonstrates effectiveness, the two companies intend to apply to USDA to enable commercial vet sales under APHIS.
Applied DNA Granted U.S. Patent Covering Methods of Utilizing DNA Tagged Submicron Particles for Authentication
February 25, 2021
Newly granted patent has applicability in the DNA tagging of pharmaceutical, nutraceutical and personal care excipients.
Thinking about buying stock in Vascular Biogenics, Oncolytics Biotech, Protalix Biotherapeutics, AMC Entertainment, or Applied DNA Sciences?
February 23, 2021
Applied DNA to Provide Back-To-Campus COVID-19 Surveillance Testing to LIM College
February 19, 2021
NYC-based LIM College joins other education institutions relying on Applied DNA's safeCircle service to ensure a safe learning environment.
Applied DNA Reports First Fiscal Quarter 2021 Revenues at Upper End of Guided Range
February 11, 2021
Applied DNA and Cytocheck Detect First Instance of SARS-CoV-2 B.1.1.7 Variant in Kansas
February 11, 2021
Linea(TM) COVID-19 Assay Kit utilized in genomic surveillance mode detects first instance of SARS-CoV-2 B.1.1.7 (UK) variant in Kansas.
Applied DNA Schedules Fiscal 2021 First Quarter Financial Results Conference Call and Webcast for Thursday, February 11, 2021
February 05, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) announced today that it will report fiscal 2021 first quarter financial results after market close on Thursday, February 11, 2021. The Company’s management...